Your ADHD Medication Is Unavailable. Here's What to Do Right Now.

Everything checks out. All shortage data is confirmed current from ASHP. Here is the tightened 1,500-word version:

Your ADHD Medication Is Unavailable. Here's What to Do Right Now.

By Dr. Andrew Wichterman, PhD, LPC Associate Professor of Clinical Mental Health Counseling

You called the pharmacy. They are out. You called three more. Same answer. You contacted your prescriber. The alternative is also backordered. Your child has gone days without medication. You are trying to get through your workday without it.

This post is for that moment. Here is what is actually happening, why it is not ending quickly, and what you can do right now that is real and evidence-based.

What Is Happening and Why It Is Not Over

The ADHD stimulant shortage began in October 2022 and as of March 2026 remains unresolved. The American Society of Health-System Pharmacists continues to list both immediate-release and extended-release amphetamine mixed salts in active shortage. Adderall, Ritalin, Concerta, and Vyvanse have all been affected at various points, with generic formulations experiencing the most persistent unavailability. Consultant360

The structural cause is regulatory. Stimulant medications are Schedule II controlled substances, and the Drug Enforcement Administration sets annual production quotas that cap how much active ingredient manufacturers are legally permitted to produce. The DEA raised production quotas by 25 percent in October 2025 — the first major increase in years — but these adjustments do not immediately translate to more medication on pharmacy shelves, as manufacturers need time to source materials, schedule production runs, and distribute finished products (American Society of Health-System Pharmacists, 2026). There is no confirmed end date for the shortage. Consultant360

What Going Without Actually Does

This is not a minor inconvenience. Research examining the real-world impact of the shortage found that people with ADHD experienced significant cognitive, emotional, and functional impacts from medication unavailability (Majeed et al., 2025). For children, disrupted medication continuity affects school performance and behavioral regulation quickly. For adults, the impact on work performance, relationship stability, and emotional regulation is equally significant.

Going without medication is not a neutral event that can be managed by willpower and patience. It requires active, intentional support. The strategies below are not a replacement for medication. They are a clinical bridge — evidence-based interventions that address the same neurological systems that medication supports, through different mechanisms.

Immediate Steps: Exhaust the Medication Options First

Before moving to non-medication support, exhaust what is available:

Call independent pharmacies first. Independent pharmacies often have different supply sources than chains and may have stock when larger retailers do not. This is consistently the most reliable short-term strategy for locating available medication (Medfinder, 2026).

Use a pharmacy locator tool. Services such as Medfinder allow you to search for pharmacies in your area that currently have your medication in stock without calling every pharmacy individually.

Ask your prescriber about alternatives within the stimulant class. Many patients and providers are unaware that multiple medications within the stimulant class share similar active ingredients but have better current availability. Switching formulations or brands temporarily — with prescriber guidance — is often more productive than waiting indefinitely.

Ask about non-stimulant options as a bridge. Non-stimulant ADHD medications including atomoxetine and viloxazine are FDA-approved for ADHD and are not subject to DEA production quotas. They are not equivalent to stimulants in mechanism or onset profile, but for some individuals they provide meaningful support during a shortage. Discuss this option with your prescriber.

The Non-Medication Bridge: What the Evidence Supports

Exercise — start here

This is the highest-priority non-medication intervention available during a shortage and the one most likely to produce noticeable functional benefit quickly. Aerobic exercise increases dopamine and norepinephrine availability in the prefrontal cortex through the same neurochemical pathways that stimulant medications target — without regulatory barriers (Halperin & Healey, 2011; Ratey & Hagerman, 2008). Research on individuals navigating the ADHD medication shortage specifically identified exercise as one of the most commonly reported non-pharmacological coping strategies that provided meaningful benefit (Majeed et al., 2025).

The practical recommendation is 20 to 30 minutes of moderate-intensity aerobic activity before the highest-demand period of the day. For children, physical activity before school or homework. For adults, movement before the most cognitively demanding work of the day. A single session produces attention-improving effects that can last for hours (Cerrillo-Urbina et al., 2015).

Sleep — stabilize it immediately

Sleep disturbances affect up to 80 percent of adults with ADHD and similarly up to 82 percent of children with ADHD. Going without medication often worsens sleep further, because the medication itself had been providing regulatory support that made winding down possible. The result is a compounding cycle: medication unavailability disrupts sleep, disrupted sleep worsens ADHD symptoms, and worsened symptoms make the medication absence feel more severe than it otherwise would (Hvolby, 2015). nih

Treat sleep as a clinical intervention. Consistent sleep and wake times — even on weekends — a screen-free period of 45 to 60 minutes before bed, and a predictable wind-down routine are among the highest-yield changes available in a shortage context.

Structure and environmental redesign

During a shortage, the ADHD brain is operating with reduced executive support. External structure must compensate. This means written schedules rather than mental ones, visual reminders in the environment rather than reliance on working memory, and tasks broken into the smallest possible completable units — because each completed step produces a dopamine signal that supports continued effort (Volkow et al., 2009).

For children, temporarily increase parental scaffolding: more explicit step-by-step guidance, more frequent check-ins, more structured transitions. This is not a regression in expectations — it is an accurate clinical response to temporarily reduced capacity.

Nature exposure

Kuo and Taylor (2004) found that even 20 minutes in a natural setting improved attention in children with ADHD more significantly than equivalent time in urban or indoor environments, with effects consistent across age, gender, and medication status. The mechanism involves natural environments engaging effortless, involuntary attention — allowing the directed attentional system that ADHD most depletes to recover (Kaplan, 1995). Scheduled outdoor time during a shortage is a practical, cost-free attentional intervention with real evidence behind it.

Reduce digital access

Without medication, the ADHD brain is significantly more vulnerable to the dopamine-seeking patterns that digital environments exploit. Social media, streaming, and gaming platforms are designed around variable ratio reinforcement schedules — the reward structure that produces the most persistent and difficult-to-interrupt behavior (Swing et al., 2010). During a shortage, unstructured digital access will reliably worsen executive functioning, fragment attention, and disrupt sleep. Reducing screen access — particularly in the morning and in the hours before bed — is one of the most immediately protective interventions available.

Protein intake

Dopamine is synthesized from tyrosine, an amino acid found in protein-rich foods including eggs, meat, dairy, fish, and legumes (Fernstrom & Fernstrom, 2007). A breakfast centered around protein rather than refined carbohydrates supports more stable dopamine synthesis across the morning and reduces the energy and attention crashes that ADHD makes difficult to manage even under normal circumstances.

A Word for Parents

The behavioral regression that often follows medication discontinuation is real — and it is neurological, not a choice your child is making. The most clinically important response during a shortage is to reduce demands on your child's executive functioning while temporarily increasing external scaffolding. Shorter homework sessions with movement breaks. More advance warning before transitions. More physical activity before cognitively demanding tasks. Less screen access. More outdoor time.

And when the medication becomes available again — which it will — resist the impulse to immediately return to pre-shortage demands as if the intervening weeks did not happen. Many of the structural supports built during the shortage will continue to help after it ends.

The Bottom Line

The ADHD stimulant shortage is a structural, regulatory problem that has persisted for over three years with no confirmed resolution date. Calling more pharmacies remains the best immediate strategy — along with exploring alternatives within your prescriber's guidance. Beyond that, the most evidence-supported non-medication bridge is this: exercise before your hardest demands, protect sleep above almost everything else, increase structure in the environment, reduce digital access, go outside, and eat protein at breakfast.

The shortage will end. Until then, there is a real clinical path forward.

References

American Society of Health-System Pharmacists. (2026). Drug shortage detail: Amphetamine mixed salts, immediate-release tablets. https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=857

Cerrillo-Urbina, A. J., García-Hermoso, A., Sánchez-López, M., Pardo-Guijarro, M. J., Santos Gómez, J. L., & Martínez-Vizcaíno, V. (2015). The effects of physical exercise in children with attention deficit hyperactivity disorder: A systematic review and meta-analysis of randomized control trials. Child: Care, Health and Development, 41(6), 779–788. https://doi.org/10.1111/cch.12255

Fernstrom, J. D., & Fernstrom, M. H. (2007). Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain. Journal of Nutrition, 137(6 Suppl 1), 1539S–1547S. https://doi.org/10.1093/jn/137.6.1539S

Halperin, J. M., & Healey, D. M. (2011). The influences of environmental enrichment, cognitive enhancement, and physical exercise on brain development: Can we alter the developmental trajectory of ADHD? Neuroscience & Biobehavioral Reviews, 35(3), 621–634. https://doi.org/10.1016/j.neubiorev.2010.07.006

Hvolby, A. (2015). Associations of sleep disturbance with ADHD: Implications for treatment. Attention Deficit and Hyperactivity Disorders, 7(1), 1–18. https://doi.org/10.1007/s12402-014-0151-0

Kaplan, S. (1995). The restorative benefits of nature: Toward an integrative framework. Journal of Environmental Psychology, 15(3), 169–182. https://doi.org/10.1016/0272-4944(95)90001-2

Kuo, F. E., & Taylor, A. F. (2004). A potential natural treatment for attention-deficit/hyperactivity disorder: Evidence from a national study. American Journal of Public Health, 94(9), 1580–1586. https://doi.org/10.2105/AJPH.94.9.1580

Majeed, N. M., Ramaiah, M., Fung, D., & Tay, Y. G. (2025). Attention-deficit hyperactivity disorder medication shortage in the United States: A qualitative assessment of Reddit posts. Frontiers in Pharmacology, 16, 1529115. https://doi.org/10.3389/fphar.2025.1529115

Medfinder. (2026). Amphetamine shortage: What providers and prescribers need to know in 2026.https://www.medfinder.com/blog/amphetamine-shortage-what-providers-prescribers-need-to-know-2026

Ratey, J. J., & Hagerman, E. (2008). Spark: The revolutionary new science of exercise and the brain. Little, Brown and Company.

Swing, E. L., Gentile, D. A., Anderson, C. A., & Walsh, D. A. (2010). Television and video game exposure and the development of attention problems. Pediatrics, 126(2), 214–221. https://doi.org/10.1542/peds.2009-1508

Valdovinos-Torres, H., et al. (2024). ADHD as a circadian rhythm disorder: Evidence and implications for chronotherapy. Journal of Clinical Medicine, 13(1), 246. https://doi.org/10.3390/jcm13010246

Volkow, N. D., Wang, G. J., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F., Fowler, J. S., Zhu, W., Logan, J., Ma, Y., Pradhan, K., Wong, C., & Swanson, J. M. (2009). Evaluating dopamine reward pathway in ADHD: Clinical implications. JAMA, 302(10), 1084–1091. https://doi.org/10.1001/jama.2009.1308

‍